Filter Results :

Your search for Immune returned 152 reports

Sort by


Autoimmune Partnering Terms and Agreements

01 Mar 2015  |  Published by:  CurrentPartnering
The Autoimmune Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the autoimmune partnering deals and agreements entered into by the worlds leading healthcare companies. -Trends in autoimmune partnering deals-Average deal terms for headline, ...

$ 2,995.00

Read More

Competitor Analysis: IDO & TDO Inhibitors - Novel Immune Response Checkpoint Modulators

01 Mar 2015  |  Published by:  La Merie Business Intelligence
The Competitive Intelligence report aboutIDO & TDO Inhibitors - Novel Immune Response Checkpoint Modulators provides a competitor analysis as of March 2015 in the development pipeline of novel inhibitors of indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3- dioxygenase (TDO) for treatme...

$ 163.31

Read More

Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H1 2015

10 Feb 2015  |  Published by:  Global Markets Direct
Summary‘Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H1 2015’, provides an overview of the Acquired (Autoimmune) Hemolytic Anemia’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Acquired (Autoimmune) Hemolytic Anemia, complete wit...

$ 2,000.00

Read More

TapImmune Inc. (TPIV) - Financial and Strategic SWOT Analysis Review

01 Feb 2015  |  Published by:  GlobalData
SummaryTapImmune Inc. (TapImmune) is a biotechnology company. The company develops peptide and gene-based immunotherapeutics and vaccines for the treatment of oncology and infectious disease. Its immunotherapy technologies are used to prevent emerging viral pathogens for pandemics and biodefense. Ta...

$ 300.00

Read More

Adimmune Corporation (4142) - Financial and Strategic SWOT Analysis Review

01 Feb 2015  |  Published by:  GlobalData
SummaryAdimmune Corporation (Adimmune) is a pharmaceutical company. The company manufactures products, such as vaccines, diagnostics, and biological products. The company’s vaccine products include Japan encephalitis vaccine, tetanus toxoid adsorbed vaccine, influenza vaccine, and ah1n1 vaccine. It ...

$ 300.00

Read More

Global Immune Function Agents Industry 2015 Market Research Report

30 Jan 2015  |  Published by:  9Dimen Research
2015 GlobalImmune Function Agents Industry Report is a professional and in-depth research report on the world's major regional market conditions of theImmune Function Agents industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan ...

$ 2,850.00

Read More

Primary Immune Deficiency (PID) - Pipeline Review, H2 2014

31 Dec 2014  |  Published by:  Global Markets Direct
Summary ‘Primary Immune Deficiency (PID) - Pipeline Review, H2 2014’, provides an overview of the Primary Immune Deficiency (PID)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Primary Immune Deficiency (PID), complete with comparative analys...

$ 2,000.00

Read More

Immune Design Corp. - Product Pipeline Review - 2014

10 Dec 2014  |  Published by:  Global Markets Direct
Summary'Immune Design Corp. - Product Pipeline Review - 2014’, provides an overview of the Immune Design Corp.’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Immune Design Corp.’s, complete with comp...

$ 1,500.00

Read More

Autoimmune Drugs Markets in China

01 Dec 2014  |  Published by:  Asia Market Info and Dev Co.
China's demand for Autoimmune Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & exp...

$ 4,000.00

Read More

SYNIMMUNE GmbH - Product Pipeline Review - 2014

24 Nov 2014  |  Published by:  Global Markets Direct
Summary‘SYNIMMUNE GmbH - Product Pipeline Review - 2014’, provides an overview of the SYNIMMUNE GmbH’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of SYNIMMUNE GmbH’s, complete with comparative analysi...

$ 1,500.00

Read More

Immune Response BioPharma, Inc. - Product Pipeline Review - 2014

24 Nov 2014  |  Published by:  Global Markets Direct
Summary‘Immune Response BioPharma, Inc. - Product Pipeline Review - 2014’, provides an overview of the Immune Response BioPharma, Inc.’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Immune Response B...

$ 1,500.00

Read More

Immune-tree International, Inc. - Strategic SWOT Analysis Review

21 Nov 2014  |  Published by:  GlobalData
SummaryImmune-tree International, Inc. (Immune tree) is a healthcare product company. The company develops and manufactures colostrum and colostrum based products. Immune tree’s products include colostrum capsules, colostrum 2.5oz powder, colostrum 6.5oz powder, colostrum kilo powder, colostrum pine...

$ 300.00

Read More

Immune Network, Ltd. - Strategic SWOT Analysis Review

21 Nov 2014  |  Published by:  GlobalData
SummaryImmune Network, Ltd. (INR) is a healthcare company. The company discovers and develops drugs for the treatment of various immunological diseases in Canada. It offers pre-clinical and clinical immunotherapeutics and immunitor products. The company provides vaccines against microbial and fungal...

$ 300.00

Read More

TapImmune Inc. (TPIV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

21 Nov 2014  |  Published by:  GlobalData
SummaryTapImmune Inc. (TapImmune) is a biotechnology company. The company develops peptide and gene-based immunotherapeutics and vaccines for the treatment of oncology and infectious disease. Its immunotherapy technologies are used to prevent emerging viral pathogens for pandemics and biodefense. Ta...

$ 250.00

Read More

Omnimmune Holdings, Inc. (OMMH) - Financial and Strategic SWOT Analysis Review

21 Nov 2014  |  Published by:  GlobalData
SummaryOmnimmune Holdings, Inc. (Omnimmune) is a development-stage biotechnology company, engaged in providing diagnostic, prognostic and therapeutic interventions in the clinical management of cancer. Omnimmune acquired the licensed rights to breakthrough platform monoclonal antibody technologies a...

$ 300.00

Read More
Total 152 records.